E Fund Management Co. Ltd. Makes New Investment in CVS Health Corporation $CVS

E Fund Management Co. Ltd. acquired a new position in shares of CVS Health Corporation (NYSE:CVS) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 7,825 shares of the pharmacy operator’s stock, valued at approximately $809,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. BlackRock Inc. bought a new stake in CVS Health during the second quarter worth $12,747,462,000. Norges Bank bought a new position in shares of CVS Health in the 4th quarter valued at about $1,666,265,000. Wellington Management Group LLP increased its stake in shares of CVS Health by 193.2% during the 4th quarter. Wellington Management Group LLP now owns 18,564,392 shares of the pharmacy operator’s stock worth $1,473,270,000 after purchasing an additional 12,233,675 shares during the last quarter. Pzena Investment Management LLC bought a new stake in shares of CVS Health in the 2nd quarter valued at about $1,217,558,000. Finally, Bank of New York Mellon Corp acquired a new stake in CVS Health in the 2nd quarter valued at about $932,454,000. 80.66% of the stock is owned by institutional investors.

CVS Health Stock Performance

NYSE CVS opened at $93.58 on Thursday. The firm’s 50 day simple moving average is $102.32 and its 200 day simple moving average is $88.69. The firm has a market capitalization of $119.68 billion, a price-to-earnings ratio of 24.76, a P/E/G ratio of 0.91 and a beta of 0.61. The company has a current ratio of 0.87, a quick ratio of 0.66 and a debt-to-equity ratio of 0.74. CVS Health Corporation has a 1 year low of $69.51 and a 1 year high of $110.68.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.87 by $0.71. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The company had revenue of $106.10 billion for the quarter, compared to analyst estimates of $100.03 billion. During the same quarter last year, the company posted $1.81 EPS. The company’s revenue for the quarter was up 7.3% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. As a group, research analysts expect that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Stockholders of record on Thursday, July 23rd were paid a $0.665 dividend. This represents a $2.66 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date was Thursday, July 23rd. CVS Health’s dividend payout ratio is presently 70.37%.

Analysts Set New Price Targets

A number of analysts have recently issued reports on CVS shares. Weiss Ratings raised CVS Health from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Wednesday, August 5th. Barclays boosted their target price on CVS Health from $106.00 to $108.00 and gave the stock an “overweight” rating in a report on Thursday, August 6th. Mizuho raised their price target on CVS Health from $110.00 to $115.00 and gave the company an “outperform” rating in a report on Monday, June 8th. Deutsche Bank Aktiengesellschaft lifted their price objective on shares of CVS Health from $88.00 to $92.00 and gave the stock a “buy” rating in a research report on Thursday, May 7th. Finally, UBS Group upped their price objective on shares of CVS Health from $122.00 to $126.00 and gave the company a “buy” rating in a report on Thursday, August 6th. Twenty-two analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, CVS Health currently has an average rating of “Moderate Buy” and a consensus target price of $107.17.

CVS Health Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.